Healthcare provider profile · identity verified

David Berrey, D.O.

Internal Medicine · MESA, AZ · NPI 1568604593

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	757	235
Rosuvastatin Calcium	Rosuvastatin Calcium	640	185
Levothyroxine Sodium	Levothyroxine Sodium	622	181
Lisinopril	Lisinopril	538	169
Amlodipine Besylate	Amlodipine Besylate	398	118
Losartan Potassium	Losartan Potassium	372	121
Pantoprazole Sodium	Pantoprazole Sodium	261	85
Metformin Hcl	Metformin Hcl	254	77
Tamsulosin Hcl	Tamsulosin Hcl	226	73
Hydrochlorothiazide	Hydrochlorothiazide	222	78
Omeprazole	Omeprazole	215	79
Metoprolol Succinate	Metoprolol Succinate	205	67
Gabapentin	Gabapentin	170	64
Pravastatin Sodium	Pravastatin Sodium	168	57
Ezetimibe	Ezetimibe	159	55
Metoprolol Tartrate	Metoprolol Tartrate	152	51
Potassium Chloride	Potassium Chloride	151	53
Famotidine	Famotidine	146	53
Simvastatin	Simvastatin	145	40
Duloxetine Hcl	Duloxetine Hcl	133	45
Ozempic	Semaglutide	133	29
Sertraline Hcl	Sertraline Hcl	123	37
Clopidogrel	Clopidogrel Bisulfate	121	40
Albuterol Sulfate Hfa	Albuterol Sulfate	119	57
Montelukast Sodium	Montelukast Sodium	116	36
Jardiance	Empagliflozin	114	35
Eliquis	Apixaban	112	43
Trazodone Hcl	Trazodone Hcl	111	41
Allopurinol	Allopurinol	108	35
Metformin Hcl Er	Metformin Hcl	108	37
Tramadol Hcl	Tramadol Hcl	103	26
Finasteride	Finasteride	99	32
Furosemide	Furosemide	98	48
Alendronate Sodium	Alendronate Sodium	91	30
Liothyronine Sodium	Liothyronine Sodium	88	30
Tizanidine Hcl	Tizanidine Hcl	88	47
Atenolol	Atenolol	87	24
Carvedilol	Carvedilol	83	28
Doxazosin Mesylate	Doxazosin Mesylate	83	31
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	81	21
Synthroid	Levothyroxine Sodium	79	21
Glimepiride	Glimepiride	74	23
Warfarin Sodium	Warfarin Sodium	70	17
Lovastatin	Lovastatin	68	22
Prednisone	Prednisone	63	40
Spironolactone	Spironolactone	63	24
Citalopram Hbr	Citalopram Hydrobromide	62	19
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	60	15
Pioglitazone Hcl	Pioglitazone Hcl	60	16
Meloxicam	Meloxicam	59	21
Acyclovir	Acyclovir	58	16
Donepezil Hcl	Donepezil Hcl	56	18
Hydralazine Hcl	Hydralazine Hcl	51	17
Hydroxyzine Hcl	Hydroxyzine Hcl	50	18
Escitalopram Oxalate	Escitalopram Oxalate	48	18
Celecoxib	Celecoxib	47	16
Pregabalin	Pregabalin	47	12
Fluticasone Propionate	Fluticasone Propionate	45	18
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	42	16
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	41	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	40	12
Ropinirole Hcl	Ropinirole Hcl	40	13
Alprazolam	Alprazolam	39	20
Sumatriptan Succinate	Sumatriptan Succinate	39	12
Doxycycline Hyclate	Doxycycline Hyclate	38	27
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	38	15
Methylprednisolone	Methylprednisolone	38	35
Fluoxetine Hcl	Fluoxetine Hcl	37	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	37	12
Trulicity	Dulaglutide	37	13
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	35	suppressed
Valsartan	Valsartan	35	13
Lorazepam	Lorazepam	34	11
Mirtazapine	Mirtazapine	33	13
Zolpidem Tartrate	Zolpidem Tartrate	32	suppressed
Clonazepam	Clonazepam	31	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	31	11
Propranolol Hcl	Propranolol Hcl	30	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	30	suppressed
Buspirone Hcl	Buspirone Hcl	29	11
Estradiol	Estradiol	29	12
Fenofibrate	Fenofibrate	29	suppressed
Ondansetron Odt	Ondansetron	29	suppressed
Bupropion Xl	Bupropion Hcl	28	11
Paroxetine Hcl	Paroxetine Hcl	28	suppressed
Terazosin Hcl	Terazosin Hcl	28	suppressed
Glipizide	Glipizide	27	suppressed
Benazepril Hcl	Benazepril Hcl	26	suppressed
Bupropion Hcl Sr	Bupropion Hcl	26	suppressed
Glipizide Er	Glipizide	26	suppressed
Mounjaro	Tirzepatide	25	suppressed
Irbesartan	Irbesartan	24	suppressed
Lansoprazole	Lansoprazole	24	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	24	suppressed
Humalog Kwikpen U-100	Insulin Lispro	23	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	22	18
Ipratropium Bromide	Ipratropium Bromide	22	13
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	22	22
Dicyclomine Hcl	Dicyclomine Hcl	21	suppressed
Nifedipine Er	Nifedipine	21	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	21	19
Amitriptyline Hcl	Amitriptyline Hcl	20	suppressed
Azithromycin	Azithromycin	20	18
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	20	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	20	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	19	suppressed
Baclofen	Baclofen	19	suppressed
Azelastine Hcl	Azelastine Hcl	18	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Diazepam	Diazepam	17	suppressed
Temazepam	Temazepam	17	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	17	suppressed
Bydureon Bcise	Exenatide Microspheres	16	suppressed
Ibuprofen	Ibuprofen	16	suppressed
Levetiracetam	Levetiracetam	16	suppressed
Xarelto	Rivaroxaban	16	suppressed
Cefdinir	Cefdinir	15	14
Eszopiclone	Eszopiclone	15	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	15	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	14	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Ondansetron Hcl	Ondansetron Hcl	14	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	14	suppressed
Entresto	Sacubitril/Valsartan	13	suppressed
Farxiga	Dapagliflozin Propanediol	13	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	13	suppressed
Januvia	Sitagliptin Phosphate	13	suppressed
Fluconazole	Fluconazole	12	11
Sucralfate	Sucralfate	12	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	12	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	11	suppressed
Linzess	Linaclotide	11	suppressed
Meclizine Hcl	Meclizine Hcl	11	suppressed
Nystatin	Nystatin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error